{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:42:06Z","timestamp":1787010126740,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1097\/mbc.0b013e328355111f","type":"journal-article","created":{"date-parts":[[2012,6,8]],"date-time":"2012-06-08T17:07:16Z","timestamp":1339175236000},"page":"680-687","source":"Crossref","is-referenced-by-count":22,"title":["Thrombin generation assay"],"prefix":"10.1097","volume":"23","author":[{"given":"Gianluca","family":"Campo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Pavasini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Pollina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Fileti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jlenia","family":"Marchesini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Tebaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210203","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.jacc.2010.09.077","article-title":"Composition of coronary thrombus in acute myocardial infarction.","volume":"57","author":"Silvain","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R2-2-20210203","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2003-12-4195","article-title":"New anticoagulants.","volume":"105","author":"Hirsh","year":"2005","journal-title":"Blood"},{"key":"R3-2-20210203","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1538-7933.2004.0584a.x","article-title":"Assessment of three chromogenic and one clotting assays for the measurement of synthetic pentasaccaharide fondaparinux anti-Xa activity.","volume":"2","author":"Depasse","year":"2004","journal-title":"J Thromb Haemost"},{"key":"R4-2-20210203","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0049-3848(11)70007-X","article-title":"Thrombin generation tests.","volume":"127","author":"Castoldi","year":"2011","journal-title":"Thromb Res"},{"key":"R5-2-20210203","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1309\/AJCP6AY4HTRAAJFQ","article-title":"Optimization of plasma flourogenic thrombin-generation assays.","volume":"132","author":"Chandler","year":"2009","journal-title":"Am J Clin Pathol"},{"key":"R6-2-20210203","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1213\/01.ane.0000278868.23814.3b","article-title":"Thrombin generation assay and viscoelastic coagulation monitors demonstrate differences in the mode of thrombin inhibition between unfractionated heparin and bivalirudin.","volume":"105","author":"Tanaka","year":"2007","journal-title":"Anesth Analg"},{"key":"R7-2-20210203","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1111\/j.1538-7836.2007.02753.x","article-title":"Three different patterns of calibrated automated thrombogram obtained with six different anticoagulants.","volume":"5","author":"Samama","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R8-2-20210203","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1538-7836.2007.02477.x","article-title":"Effect of the antifactor Xa and antifactor IIa activities of low-molecular-weight heparins upon the phases of thrombin generation.","volume":"5","author":"Gerotziafas","year":"2007","journal-title":"J Thromb Haemost"},{"key":"R9-2-20210203","first-page":"160","article-title":"Is thrombin generation the new rapid, reliable and relevant pharmacological tool for the development of anticoagulant drugs Pharmacol R","volume":"59","author":"Robert","year":"2009","journal-title":"es"},{"key":"R10-2-20210203","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCULATIONAHA.106.685974","article-title":"Beyond unfractionated heparin and warfarin: current and future advances.","volume":"116","author":"Hirsh","year":"2007","journal-title":"Circulation"},{"key":"R11-2-20210203","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1016\/j.thromres.2011.07.026","article-title":"In vitro study of the anticoagulant effects of edoxaban and its effect on thrombin generation in comparison to fondaparinux.","volume":"129","author":"Samama","year":"2012","journal-title":"Thromb Res"},{"key":"R12-2-20210203","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.thromres.2008.07.007","article-title":"Reversal of the inhibitory effect of fondaparinux on thrombin generation by rFVIIa, aCCP and PCC.","volume":"123","author":"Desmurs-Clavel","year":"2009","journal-title":"Thromb Res"},{"key":"R13-2-20210203","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1161\/01.CIR.0000038501.87442.02","article-title":"Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccaharide fondaparinux in healthy volunteers.","volume":"106","author":"Bijsterveld","year":"2002","journal-title":"Circulation"},{"key":"R14-2-20210203","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.thromres.2010.10.017","article-title":"Elevated factor VIII enhances thrombin generation in the presence of factor VIII-deficiency, factor XI-deficiency or fondaparinux.","volume":"127","author":"Szlam","year":"2011","journal-title":"Thromb Res"},{"key":"R15-2-20210203","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1538-7836.2010.03739.x","article-title":"Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin activatable fibrinolysis inhibitor.","volume":"8","author":"Ammollo","year":"2010","journal-title":"J Thromb Haemost"},{"key":"R16-2-20210203","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1365-2141.2008.07279.x","article-title":"Wide variation in thrombin generation in patients with atrial fibrillation and therapeutic International Normalized Ratio is not due to inflammation.","volume":"142","author":"Gatt","year":"2008","journal-title":"Br J Haematol"},{"key":"R17-2-20210203","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1538-7836.2004.00676.x","article-title":"Increased levels of soluble tissue factor during long-term treatment with warfarin in patients after an acute myocardial infarction.","volume":"2","author":"Seljeflot","year":"2004","journal-title":"J Thromb Haemost"},{"key":"R18-2-20210203","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2141.2004.05222.x","article-title":"Low-intensity warfarin reduces thrombin generation and fibrin turnover, but not low-grade inflammation, in men at risk of myocardial infarction.","volume":"127","author":"MacCallum","year":"2004","journal-title":"Br J Haematol"},{"key":"R19-2-20210203","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.CIR.0000025419.95769.F0","article-title":"Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy.","volume":"106","author":"Cipollone","year":"2002","journal-title":"Circulation"},{"key":"R20-2-20210203","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.CIR.0000153810.81187.7D","article-title":"Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients.","volume":"111","author":"Sanguigni","year":"2005","journal-title":"Circulation"},{"key":"R21-2-20210203","first-page":"483","article-title":"Is fibrin formation and thrombin generation increased during and after an acute coronary syndrome Thromb R","volume":"128","author":"Skeppholm","year":"2011","journal-title":"es"},{"key":"R22-2-20210203","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1538-7836.2009.03720.x","article-title":"Apolipoprotein C-III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation.","volume":"8","author":"Oliveiri","year":"2010","journal-title":"J Thromb Haemost"},{"key":"R23-2-20210203","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1538-7836.2007.02799.x","article-title":"Thrombin generation in acute coronary syndrome and stable coronary artery disease: dependence on plasma factor composition.","volume":"6","author":"Brummel-Ziedinis","year":"2008","journal-title":"J Thromb Haemost"},{"key":"R24-2-20210203","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/hc0802.104456","article-title":"Effect of abciximab on prothrombin activation and thrombin generation in acute coronary syndromes without ST-segment elevation: GUSTO IV ACS Italian Hematologic substudy.","volume":"105","author":"Merlini","year":"2002","journal-title":"Circulation"},{"key":"R25-2-20210203","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1161\/01.CIR.91.7.1929","article-title":"Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes.","volume":"91","author":"Granger","year":"1995","journal-title":"Circulation"},{"key":"R26-2-20210203","doi-asserted-by":"crossref","first-page":"e27852","DOI":"10.1371\/journal.pone.0027852","article-title":"Anticoagulants and the propagation phase of thrombin generation.","volume":"6","author":"Orfeo","year":"2011","journal-title":"PloS ONE"},{"key":"R27-2-20210203","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1001\/archinternmed.2011.536","article-title":"Prognostic impact of hospital readmissions after primary percutaneous coronary intervention.","volume":"171","author":"Campo","year":"2011","journal-title":"Arch Intern Med"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MBC.0b013e328355111f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T22:30:38Z","timestamp":1620945038000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-201212000-00002"}},"subtitle":["a new tool to predict and optimize clinical outcome in cardiovascular patients?"],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e328355111f","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}